Guillain-Barré Sendromu: Nörolojik Acil Durumlarda Tanı ve Yönetim

Farook AM, Priyankara D, Aluwihare C, Mendis A. A rare case of paraneoplastic Guillain-Barré syndrome in a patient with endometrial cancer. Eur J Case Rep Intern Med. Published online December 5, 2023. doi:10.12890/2023_004077

Ullah MW, Qaseem A, Amray A, Ullah MW, Qaseem A, Amray A. Post Vaccination Guillain Barre Syndrome: A Case Report. Cureus. 2018;10. doi:10.7759/cureus.2511

Suleiman N, Eledrisi M. Guillain-Barre Syndrome Associated With Pulmonary Tuberculosis. J Med Cases. 2013;4(10):696-698. doi:10.4021/jmc.v4i10.1288

Doets AY, Verboon C, van den Berg B, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866-2877. doi:10.1093/brain/awy232

Guillain-Barré Syndrome in a Boy With Lung Fluke Infection: Case Report and Literature Review - Cui-Wei Yang, Feng Gao, Zhe-Zhi Xia, 2015. Accessed September 14, 2024. https://journals.sagepub.com/doi/10.1177/0883073814546689

Gunatilake SSC, Wimalaratna H. Guillain-Barré syndrome presenting with Raynaud’s phenomenon: a case report. BMC Neurol. 2014;14(1):174. doi:10.1186/s12883-014-0174-3

Dalipi T, Sulejmani H, Zafirova I, Bogdanovski N. CLINICAL FEATURES AND TREATMENT MODALITIES OF THE GUILLAIN-BARRE SYNDROME A CASE REPORT. J Morphol Sci. 2024;7(1):193-197.

Palaiodimou L, Stefanou MI, Katsanos AH, et al. Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3517-3529. doi:10.1111/ene.14860

Ashrafi MR, Mohammadalipoor A, Naeini AR, et al. Clinical Characteristics and Electrodiagnostic Features of Guillain-Barré Syndrome Among the Pediatric Population. J Child Neurol. 2020;35(7):448-455. doi:10.1177/0883073820905157

Yanagida H, Sugimoto K, Izu A, Wada N, Sakata N, Takemura T. Guillain-Barré Syndrome and Crohn disease: A Case Report. J Child Neurol. 2014;29(9):NP78-NP80. doi:10.1177/0883073813503903

Guillain–Barré syndrome associated with COVID-19: A systematic review - ScienceDirect. Accessed September 14, 2024. https://www.sciencedirect.com/science/article/pii/S2666354622001685?via%3Dihub

Nagdev G, Chavan G, Sahu G, et al. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series. Cureus. 2022;14. doi:10.7759/cureus.30888

Bhagat SK, Sidhant S, Bhatta M, Ghimire A, Shah B. Clinical Profile, Functional Outcome, and Mortality of Guillain-Barre Syndrome: A Five-Year Tertiary Care Experience from Nepal. Neurol Res Int. 2019;2019(1):3867946. doi:10.1155/2019/3867946

Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain–Barré syndrome 2007–2017: what has changed? Trop Med Int Health. 2019;24(2):132-142. doi:10.1111/tmi.13181

Rane RP, Jain A, Hussain KM, et al. A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation. Cureus. 2022;14. doi:10.7759/cureus.25810

Sansone P, Giaccari LG, Aurilio C, et al. Post-Infectious Guillain–Barré Syndrome Related to SARS-CoV-2 Infection: A Systematic Review. Life. 2021;11(2):167. doi:10.3390/life11020167

Pal M. Campylobacter jejuni: An Emerging Foodborne Pathogen of Global Significance. J Exp Food Chem. 2017;03(03). doi:10.4172/2472-0542.1000130

Wallace LA, English SW, Fugate JE, Tosh PK. Acute Epstein-Barr virus infection presenting as Guillain-Barre syndrome. IDCases. 2021;25:e01196. doi:10.1016/j.idcr.2021.e01196

Petráš M, Králová Lesná I, Dáňová J, Čelko AM. Is an Increased Risk of Developing Guillain–Barré Syndrome Associated with Seasonal Influenza Vaccination? A Systematic Review and Meta-Analysis. Vaccines. 2020;8(2):150. doi:10.3390/vaccines8020150

Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE. Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009–2010 novel Influenza A (H1N1) vaccination campaign | Epidemiology & Infection. Camb Core. doi:10.1017/S0950268818001802

Gallego MDC. Guillain-barré syndrome and sars-cov2 corona virus. Vaccinate or get infected with covid? What poses less risk? Published online 2022.

Martín Arias LH, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain-Barré syndrome and influenza vaccines: A meta-analysis. Vaccine. 2015;33(31):3773-3778. doi:10.1016/j.vaccine.2015.05.013

Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2011;36(2):123-133. doi:10.1159/000324710

Tabatabaei SR, Shariatpanahi G, Azadkiya R, Karimzadeh P, Karimi A. Guillain-Barre Syndrome in a Child Infected with COVID-19. Arch Pediatr Infect Dis. 2022;10(Suppl). doi:10.5812/pedinfect.113564

Afrantou T, Kimiskidis V, Lagoudaki R, et al. Unusual phenotype of acute motor sensory axonal neuropathy with ophthalmoplegia, and anti-GD1a, -GD1b and -GM1 antibodies. Clin Exp Neuroimmunol. 2022;13(4):267-271. doi:10.1111/cen3.12704

Ralot TK, Parmar S, Gujar R, Sarkar S, Meghwal H. Study of clinical profile and prognosis in various subtypes of guillain barre syndrome patients - IP Indian J Neurosci. Accessed September 18, 2024. https://www.ijnonline.org/article-details/7989

Campbell CI, McGonigal R, Barrie JA, et al. Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model. Brain Commun. 2022;4(6):fcac306. doi:10.1093/braincomms/fcac306

Gómez-Piña JJ, Cabib C, Estañol B, Chiquete-Anaya E. Preservation of sural nerve in classic forms of Guillain-Barré in a Mexican health institution | Revista Mexicana de Neurociencia. doi:10.24875/RMN.20000024

Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain–Barré syndrome subtype: could a single study suffice? Published online January 1, 2015. doi:10.1136/jnnp-2014-307815

Mosora O, Barcutean L, Balasa R, et al. Severe Acute Motor Axonal Neuropathy Associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report. Sciendo. doi:10.2478/jccm-2021-0030

Jin J, Hu F, Qin X, et al. Very Early Neurophysiological Study in Guillain-Barre Syndrome. Eur Neurol. 2018;80(1-2):100-105. doi:10.1159/000494261

Khan SA, Das PR, Nahar Z, Dewan SMR. An updated review on Guillain-Barré syndrome: Challenges in infection prevention and control in low- and middle-income countries. SAGE Open Med. 2024;12:20503121241239538. doi:10.1177/20503121241239538

Shahrizaila N, Yuki N. Guillain-Barré Syndrome Animal Model: The First Proof of Molecular Mimicry in Human Autoimmune Disorder. BioMed Res Int. 2011;2011(1):829129. doi:10.1155/2011/829129

Auger N, Quach C, Healy-Profitós J, Dinh T, Chassé M. Early predictors of Guillain-Barré syndrome in the life course of women. Int J Epidemiol. 2018;47(1):280-288. doi:10.1093/ije/dyx181

Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report - Kamal Sharma, Supatida Tengsupakul, Omar Sanchez, Rozaleen Phaltas, Paul Maertens, 2019. Accessed September 18, 2024. https://journals.sagepub.com/doi/10.1177/2050313X19838750

Lowery MM, Taimur Malik M, Seemiller J, Tsai CS. Atypical Variant of Guillain Barre Syndrome in a Patient with COVID-19. Sciendo. doi:10.2478/jccm-2020-0038

Boubga T, Taous A, Boulahri T, et al. Isolated Facial Diplegia: A Rare Presentation of Guillain-Barré Syndrome. Cureus. 2023;15. doi:10.7759/cureus.51126

Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671-683. doi:10.1038/s41582-019-0250-9

Bashir S, Sultan T. Electrophysiologic Findings in Pediatric Guillain Barre Syndrome. Pak Armed Forces Med J. 2023;73(SUPPL-1):S411-415. doi:10.51253/pafmj.v73iSUPPL-1.11036

Durcan R, Murphy O, Reid V, Lynch T. Guillain-Barré syndrome mimicking botulism in early disease course. Published online December 1, 2018. doi:10.1136/practneurol-2018-001891

Wong AHY, Umapathi T, Nishimoto Y, Wang YZ, Chan YC, Yuki N. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst. 2015;20(1):47-51. doi:10.1111/jns.12104

A Clinical Picture of Guillain-Barré Syndrome in Children in the United States - Caitlin W. Hicks, Benjamin Kay, Sarah E. Worley, Manikum Moodley, 2010. Accessed September 28, 2024. https://journals.sagepub.com/doi/10.1177/0883073810370481

Oo WM, Giri P, Souza A de. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? Accessed September 28, 2024. https://www.jni-journal.com/article/S0165-5728(21)00246-0/fulltext

Molokwu O, Young BM, Singh M, et al. Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barré Syndrome. Cureus. 2019;11. doi:10.7759/cureus.5244

Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis | Canadian Journal of Neurological Sciences. Camb Core. doi:10.1017/cjn.2020.146

Tapia MDC, Garcia KNC, Granda LAA, et al. GUILLAIN-BARRE SYNDROME: CAUSES, EPIDEMIOLOGY,IMMUNOPATHOGENIC MECHANISMS, DIAGNOSIS, EVALUATION, DIFFERENTIAL AND TREATMENT. by Marjorie Dayanna Cordova Tapia, Karina Noemi Contreras Garcia, Luis Andres Alvarez Granda, Carmen Valeria Rojas Rojas, Bayron Mario Viscaino Cuzco, Jennyfer Tatiana Gushque Pallmay, Carla Alexandra Idrovo Idrovo, Bryam Esteban Coello Garcia. EPRA Int J Multidiscip Res IJMR. 2023;9(7):1.

Selçuk E, Köksal C. Fatal Autonomic Dysfunction Due to Guillain-Barré Syndrome After Cardiac Surgery. scite.ai. Accessed September 28, 2024. https://scite.ai/reports/fatal-autonomic-dysfunction-due-to-J1rnA0R0

Stoian A, Șerban G, Bajko Z, Andone S, Mosora O, Bălaşa A. Therapeutic plasma exchange as a first choice therapy for axonal Guillain Barré syndrome: A case based review of the literature (Review). scite.ai. Accessed September 28, 2024. https://scite.ai/reports/therapeutic-plasma-exchange-as-a-wm96WzpM

Sharma A, Aryal D. Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report. J Med Case Reports. 2018;12(1):245. doi:10.1186/s13256-018-1774-0

Patel CJ, Gosai JB, Kalariya DB, Rathod M, S. S. Clinical Profile, Electrodiagnostic Variations, Treatment and Outcome in Guillain-Barré Syndrome: Prospective Study of 78 Patients. Int J Contemp Med Res IJCMR. 2019;6(8). doi:10.21276/ijcmr.2019.6.8.42

Esa Y, Kajiyama Y, Kaido M, et al. Guillain–Barré Syndrome Associated with COVID-19 in a Japanese Male. Case Rep Neurol Med. 2022;2022(1):6837851. doi:10.1155/2022/6837851

Wang S, Luo Z, Peng T. Serum thyroid-stimulating hormone is an independent risk factor of recurrent Guillain-Barré syndrome. Muscle Nerve. 2022;65(6):688-692. doi:10.1002/mus.27539

Reversible cerebral vasoconstriction in Guillain–Barré syndrome - Journal of Clinical Neuroscience. Accessed September 28, 2024. https://www.jocn-journal.com/article/S0967-5868(15)00059-4/abstract

Anesthetic management for cesarean delivery in a Guillain-Barré syndrome patient -A case report-. Accessed September 28, 2024. https://ekja.org/journal/view.php?doi=10.4097/kjae.2013.64.3.268

Rawla P, Vellipuram AR, Bandaru SS, Raj JP. Splenic Infarct and Pulmonary Embolism as a Rare Manifestation of Cytomegalovirus Infection. Case Rep Hematol. 2017;2017(1):1850821. doi:10.1155/2017/1850821

Roodbol J, de Wit MCY, Aarsen FK, Catsman-Berrevoets CE, Jacobs BC. Long-term outcome of Guillain-Barré syndrome in children. J Peripher Nerv Syst. 2014;19(2):121-126. doi:10.1111/jns5.12068

Saini L, Krishna D, Gunasekaran PK, et al. Clinical Profile, Follow-up, and Role of Neuroimaging in Pediatric Guillain-Barré Syndrome in the COVID Era: An Ambispective Study. J Child Neurol. 2023;38(6-7):407-413. doi:10.1177/08830738231184089

Jayasundara JMHD, Samarawickrama VT, Peiris R, Aponso T, Abeynayake D. Concomitant Guillain–Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis. BMC Gastroenterol. 2022;22(1):411. doi:10.1186/s12876-022-02455-y

Fokkink WJR, van Tilburg SJ, de Winter BCM, et al. Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome. Clin Pharmacokinet. 2022;61(9):1285-1296. doi:10.1007/s40262-022-01136-z

Hayat S, Jahan I, Das A, et al. Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome. Ann Clin Transl Neurol. 2019;6(9):1849-1857. doi:10.1002/acn3.50884

Morsy S. NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome. Med Hypotheses. 2020;145:110342. doi:10.1016/j.mehy.2020.110342

Lin J, Gao Q, Xiao K, Tian D, Hu W, Han Z. Efficacy of therapies in the treatment of Guillain-Barre Syndrome: a network meta-analysis. Published online January 28, 2020. doi:10.21203/rs.2.22055/v1

A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method - Selman Kesici, Murat Tanyıldız, Filiz Yetimakman, Benan Bayrakci, 2019. Accessed September 29, 2024. https://journals.sagepub.com/doi/10.1177/0883073819826225